Synthetic vaccine for preventing and/or treating pneumococcal infections (SJ-05-0036)





Technology Name
(St. Jude Reference #)
Synthetic vaccine for preventing and/or treating pneumococcal infections (SJ-05-0036)
Description A vaccine comprising synthetically linked domains of choline binding protein A (CbpA) from Streptococcus pneumoniae is provided. It can be used to prevent pneumococcal infections such as sepsis, meningitis, and pneumonia.  Development of this vaccine is being funded by PATH Vaccine Solutions as part of a multi-institutional collaboration.
Keywords vaccine, choline binding protein, CbpA, Streptococcus pneumoniae; pneumococcal infections, sepsis,  meningitis, pneumonia
Granted Patents or Published Applications U.S. Application published June 10, 2010 as Pub. No. US2010/0143394
Related Scientific References

 

Licensing Opportunities We are currently seeking licensing opportunities in all fields for the development of this technology.

 

Contact the Office of Technology Licensing (Phone: 901-595-2342, Fax: 901-595-3148) for more information.

 

Last update: September 2010